Genky DrugStores Co., Ltd. (TYO:9267)
Japan · Delayed Price · Currency is JPY 3,625.00
+45.00 (1.26%)
Aug 6, 2026, 10:42 AM JST
Genky DrugStores Financials Overview
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 20, 2026 | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Revenue Revenue Growth | 220,638 | 220,638 | 200,786 | 184,860 | 169,059 | 154,639 |
Revenue Growth | 9.89% | 9.89% | 8.62% | 9.35% | 9.32% | 8.61% |
Gross Profit Gross Profit Growth | 44,923 | 44,923 | 40,890 | 37,621 | 34,554 | 30,954 |
Operating Income Operating Income Growth | 10,622 | 10,622 | 9,659 | 9,016 | 6,710 | 5,675 |
Net Income Net Income Growth | 7,875 | 7,875 | 7,066 | 6,324 | 4,764 | 4,420 |
Earnings Per Share EPS Growth | 257.70 | 257.70 | 232.04 | 207.94 | 156.79 | 145.44 |
EPS Growth | 11.06% | 11.06% | 11.59% | 32.62% | 7.81% | -8.54% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 20, 2026 | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Cash & Investments Cash & Investments Growth | 7,866 | 7,866 | 6,221 | 5,896 | 5,329 | 5,438 |
Total Debt Total Debt Growth | 39,640 | 39,640 | 34,374 | 30,648 | 32,354 | 30,959 |
Net Cash (Debt) Net Cash Growth | -31,774 | -31,774 | -28,153 | -24,752 | -27,025 | -25,521 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1039.77 | -1039.77 | -924.42 | -813.77 | -889.27 | -839.63 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 20, 2026 | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 16,975 | 16,975 | 12,597 | 13,256 | 8,773 | 6,076 |
Capital Expenditures CapEx Growth | -20,101 | -20,101 | -15,092 | -10,278 | -9,891 | -10,464 |
Free Cash Flow Free Cash Flow Growth | -3,126 | -3,126 | -2,495 | 2,978 | -1,118 | -4,388 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 20, 2026 | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Gross Margin | 20.36% | 20.36% | 20.36% | 20.35% | 20.44% | 20.02% |
Operating Margin | 4.81% | 4.81% | 4.81% | 4.88% | 3.97% | 3.67% |
Pretax Margin | 5.05% | 5.05% | 4.93% | 4.76% | 3.96% | 3.93% |
Profit Margin | 3.57% | 3.57% | 3.52% | 3.42% | 2.82% | 2.86% |
FCF Margin | -1.42% | -1.42% | -1.24% | 1.61% | -0.66% | -2.84% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
Dividend Per Share Dividend Per Share Growth | 13.000 | 13.000 | 13.000 | 12.500 | 12.500 | 12.500 |
Dividend Per Share Growth | 0% | 0% | 4.00% | 0% | 0% | 0% |
Dividend Yield | 0.36% | 0.39% | 0.35% | 0.46% | 0.60% | 0.81% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Jun '26 Jun 20, 2026 | Jun '25 Jun 20, 2025 | Jun '24 Jun 20, 2024 | Jun '23 Jun 20, 2023 | Jun '22 Jun 20, 2022 |
PE Ratio | 13.89 | 12.92 | 15.98 | 13.21 | 13.51 | 10.85 |
Forward PE | 13.14 | 11.92 | 14.72 | 12.94 | 13.34 | 9.69 |
P/FCF Ratio | - | - | - | 28.06 | - | - |
PS Ratio | 0.50 | 0.46 | 0.56 | 0.45 | 0.38 | 0.31 |